Dianthus Therapeutics, Inc. (DNTH)
78.22
+0.22
(+0.28%)
USD |
NASDAQ |
Mar 17, 12:28
Dianthus Therapeutics Market Cap : 3.381B for March 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Daré Bioscience, Inc. | 20.79M |
| Relmada Therapeutics, Inc. | 465.67M |
| Ocugen, Inc. | 878.76M |
| Cartesian Therapeutics, Inc. | 188.53M |
| Stoke Therapeutics, Inc. | 1.904B |
Market Cap Related Metrics
| PS Ratio | 1482.75 |
| PEG Ratio | -0.3259 |
| Price to Book Value | 6.852 |
| Price | 78.22 |
| Earnings Yield | -5.26% |
| PEGY Ratio | -0.3259 |